Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ?
Authors
Keywords
-
Journal
SEMINARS IN DIALYSIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-07-16
DOI
10.1111/sdi.12734
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism
- (2017) Geoffrey A. Block et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
- (2017) Kidney International Supplements
- Towards a structural understanding of allosteric drugs at the human calcium-sensing receptor
- (2016) Katie Leach et al. CELL RESEARCH
- Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing Receptor
- (2015) David A. Bushinsky et al. AMERICAN JOURNAL OF NEPHROLOGY
- Calcimimetic and Calcilytic Drugs: Feats, Flops, and Futures
- (2015) E. F. Nemeth et al. CALCIFIED TISSUE INTERNATIONAL
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism
- (2015) S. M. Sprague et al. Clinical Journal of the American Society of Nephrology
- Management of serum calcium reductions among patients on hemodialysis following cinacalcet initiation
- (2015) Steven M. Brunelli et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A pharmacokinetic/pharmacodynamic model for AMG 416, a novel calcimimetic peptide, following a single intravenous dose in healthy subjects
- (2014) Jun Shen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options
- (2011) J. Cunningham et al. Clinical Journal of the American Society of Nephrology
- Vitamin D Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Observational Studies and Randomized Controlled Trials
- (2010) P. Kandula et al. Clinical Journal of the American Society of Nephrology
- Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
- (2009) J. B. Wetmore et al. Clinical Journal of the American Society of Nephrology
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Cinacalcet Hydrochloride
- (2009) Desmond Padhi et al. CLINICAL PHARMACOKINETICS
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now